Inovio Pharmaceuticals, Inc. (INO)
1.25
+0.07
(+5.93%)
USD |
NASDAQ |
Aug 24, 16:00
1.23
-0.02
(-1.60%)
After-Hours: 20:00
Inovio Pharmaceuticals Total Assets (Quarterly) : 49.39M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 49.39M |
| March 31, 2026 | 49.78M |
| December 31, 2025 | 75.68M |
| September 30, 2025 | 69.39M |
| June 30, 2025 | 68.24M |
| March 31, 2025 | 87.27M |
| December 31, 2024 | 114.90M |
| September 30, 2024 | 107.06M |
| June 30, 2024 | 133.80M |
| March 31, 2024 | 129.11M |
| December 31, 2023 | 172.94M |
| September 30, 2023 | 193.10M |
| June 30, 2023 | 233.04M |
| March 31, 2023 | 266.58M |
| December 31, 2022 | 350.85M |
| September 30, 2022 | 391.97M |
| June 30, 2022 | 459.40M |
| March 31, 2022 | 445.51M |
| December 31, 2021 | 498.91M |
| September 30, 2021 | 535.76M |
| June 30, 2021 | 591.84M |
| March 31, 2021 | 654.86M |
| December 31, 2020 | 543.55M |
| September 30, 2020 | 437.81M |
| June 30, 2020 | 443.19M |
| Date | Value |
|---|---|
| March 31, 2020 | 338.92M |
| December 31, 2019 | 152.02M |
| September 30, 2019 | 151.53M |
| June 30, 2019 | 165.07M |
| March 31, 2019 | 191.17M |
| December 31, 2018 | 131.11M |
| September 30, 2018 | 140.70M |
| June 30, 2018 | 148.92M |
| March 31, 2018 | 173.66M |
| December 31, 2017 | 187.24M |
| September 30, 2017 | 203.68M |
| June 30, 2017 | 158.85M |
| March 31, 2017 | 153.31M |
| December 31, 2016 | 173.71M |
| September 30, 2016 | 194.55M |
| June 30, 2016 | 203.99M |
| March 31, 2016 | 211.29M |
| December 31, 2015 | 213.84M |
| September 30, 2015 | 230.77M |
| June 30, 2015 | 201.70M |
| March 31, 2015 | 117.86M |
| December 31, 2014 | 131.79M |
| September 30, 2014 | 134.53M |
| June 30, 2014 | 142.15M |
| March 31, 2014 | 151.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Fortress Biotech, Inc. | 316.72M |
| Tonix Pharmaceuticals Holding Corp. | 254.09M |
| Kura Oncology, Inc. | 587.79M |
| Spero Therapeutics, Inc. | 52.77M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 45.02M |
| Shareholders Equity (Quarterly) | 4.371M |
| Debt to Equity Ratio | 1.831 |
| Current Ratio | 1.00 |
| Net Debt Paydown Yield | 0.72% |